Geographical/interracial differences in polymorphic drug oxidation : current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19BERTILSSON, L.Clinical pharmacokinetics. 1995, Vol 29, Num 3, pp 192-209, issn 0312-5963Article

MASS FRAGMENTOGRAPHY IN CLINICAL PSYCHOPHARMACOLOGYBERTILSSON L; SJOEQVIST F.1973; ADV. BIOCHIM. PSYCHOPHARMACOL.; U.S.A.; DA. 1973; VOL. 7; PP. 147-159; BIBL. 1P.1/2Article

THE ABSENCE OF ISOTOPIC EFFECT DURING THE ELIMINATION OF DEUTERIUM LABELLED CARBAMAZEPINE IN THE RATOSTERLOH J; BERTILSSON L.1978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 1; PP. 83-87; BIBL. 10 REF.Article

DETERMINATION OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN PLASMA BY HIGH-SPEED LIQUID CHROMATOGRAPHY = DETERMINATION DE LA CARBAMAZEPINE ET DE SON METABOLITE EPOXYDE DANS LE PLASMA PAR CHROMATOGRAPHIE EN PHASE LIQUIDE A VITESSE ELEVEEEICHELBAUM M; BERTILSSON L.1975; J. CHROMATOGR.; NETHERL.; DA. 1975; VOL. 103; NO 1; PP. 135-140; BIBL. 24REF.Article

5-HYDROXYTRYPTAMINE DEPLETION IN MESENCEPHALIC NUCLEI OF RAT BRAIN FOLLOWING A SINGLE INFECTION OF P-CHLOROAMPHETAMINE = DIMINUTION DE LA SEROTONINE DANS LES NOYAUX MESENCEPHALIQUES DU CERVEAU DE RAT APRES INJECTION UNIQUE DE P-CHLORO-AMPHETAMINEBERTILSSON L; KOSLOW SH; COSTA E et al.1975; BRAIN RES.; NETHERL.; DA. 1975; VOL. 91; NO 2; PP. 348-350; BIBL. 13REF.Article

BROMOCRIPTINE TREATMENT OF DEPRESSIVE DISORDERS. CLINICAL AND BIOCHEMICAL EFFECTSNORDIN C; SIWERS B; BERTILSSON L et al.1981; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1981; VOL. 64; NO 1; PP. 25-33; BIBL. 2 P.Article

DISPOSITION OF PLACENTALLY TRANSFERRED CARBAMAZEPINE (TEGRETOL) IN THE NEWBORN = LE SORT DE LA CARBAMAZEPINE TRANSFEREE PAR LE PLACENTA (TEGRETOL) CHEZ LE NOUVEAU-NERANE A; BERTILSSON L; PALMER L et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 3-4; PP. 283-284; BIBL. 10REF.Article

DIFFERENTIAL EFFECT OF CHLORIMIPRAMINE AND NORTRIPTYLINE ON CEREBROSPINAL FLUID METABOLITES OF SEROTONIN AND NORADRENALINE IN DEPRESSION = L'EFFET DIFFERENTIEL DE LA CHLORIMIPRAMINE ET DE LA NORTRIPTYLINE SUR LES METABOLITES DANS LE LIQUIDE CEPHALO-RACHIDIEN DE LA SEROTONINE ET DE LA NORADRENALINE DANS LA DEPRESSIONBERTILSSON L; ASBERG M; THOREN P et al.1974; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1974; VOL. 7; NO 5; PP. 365-368; BIBL. 17REF.Article

MONOAMINE METABOLITES IN CSF AND SUICIDAL BEHAVIORTRASKMAN L; ASBERG M; BERTILSSON L et al.1981; ARCH. GEN. PSYCHIATRY; ISSN 0003-990X; USA; DA. 1981; VOL. 38; NO 6; PP. 631-636; BIBL. 70 REF.Article

PLASMA KINETICS OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE IN MAN AFTER SINGLE AND MULTIPLE DOSESEICHELBAUM M; EKBOM K; BERTILSSON L et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 5; PP. 337-341; BIBL. 15 REF.Article

CARBAMAPEZINE THERAPY IN TRIGEMINAL NEURALGIA: CLINICAL EFFECTS IN RELATION TO PLASMA CONCENTRATIONTOMSON T; TYBRING G; BERTILSSON L et al.1980; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1980; VOL. 37; NO 11; PP. 699-703; BIBL. 53 REF.Article

CARBAMAZEPINE IN TRIGERMINAL NEURALGIA: CHIMICAL EFFECTS IN RELATION TO PLASMA-CONCENTRATIONTOMSON T; TYBRING G; BERTILSSON L et al.1980; UPS. J. MED. SCI., SUPPL.; ISSN 0300-9726; SWE; DA. 1980; NO 31; PP. 45-46; BIBL. 11 REF.Article

AUTOINDUCTION OF CARBAMAZEPINE METABOLISM IN CHILDREN EXAMIDED BY A STABLE ISOTOPE TECHNIQUEBERTILSSON L; HOJER B; TYBRING G et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 1; PP. 83-88; BIBL. 18 REF.Article

THE TURNOVER RATE GAMMA -AMINOBUTYRIC ACID IN THE NUCLEI OF TELENCEPHALON: IMPLICATIONS IN THE PHARMACOLOGY OF ANTIPSYCHOTICS AND OF A MINOR TRANQUILIZER.MAO CC; MARCO E; REVUELTA A et al.1977; BIOL. PSYCHIATRY; U.S.A.; DA. 1977; VOL. 12; NO 3; PP. 359-371; BIBL. 3 P. 1/2Article

Active hydroxymetabolites of antidepressants : emphasis on E-10-hydroxy-nortriptylineNORDIN, C; BERTILSSON, L.Clinical pharmacokinetics. 1995, Vol 28, Num 1, pp 26-40, issn 0312-5963Article

Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgiaTOMSON, T; BERTILSSON, L.Archives of neurology (Chicago). 1984, Vol 41, Num 6, pp 598-601, issn 0003-9942Article

REDUCTION OF TRYPTOPHAN HYDROXYLASE ACTIVITY AND 5-HYDROXYTRYPTAMINE CONCENTRATION IN CERTAIN RAT BRAIN NUCLEI AFTER P-CHLOROAMPHETAMINENECKERS LM; BERTILSSON L; KOSLOW SH et al.1976; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1976; VOL. 196; NO 2; PP. 333-338; BIBL. 27 REF.Article

Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxydebrisoquine in urine for CYP2D6 phenotypingSVENSSON, J.-O; BERTILSSON, L.Pharmacogenetics (London). 1999, Vol 9, Num 4, pp 529-531, issn 0960-314XArticle

Interethnic factors affecting drug responseKALOW, W; BERTILSSON, L.Advances in Drug Research. 1994, Vol 25, pp 1-53, issn 0065-2490Article

Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An updateBERTILSSON, L; TOMSON, T.Clinical pharmacokinetics. 1986, Vol 11, Num 3, pp 177-198, issn 0312-5963Article

POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE: RELATED PHARMACOGENETIC ENTITIESEICHELBAUM M; BERTILSSON L; SAWE DJ et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 2; PP. 184-186; BIBL. 14 REF.Article

AGING-INDUCED CHANGES IN ACETYLCHOLINE AND SEROTONIN CONTENT OF DISCRETE BRAIN NUCLEI.MEEK JL; BERTILSSON L; CHENEY DL et al.1977; J. GERONTOL.; U.S.A.; DA. 1977; VOL. 32; NO 2; PP. 129-131; BIBL. 12 REF.Article

DISTRIBUTION AND ELIMINATION KINETICS OF CARBAMAZEPINE IN MAN = CINETIQUE DE LA REPARTITION ET DE L'ELIMINATION DE LA CARBAMAZEPINE CHEZ L'HOMMERAWLINS MD; COLLSTE P; BERTILSSON L et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 2; PP. 91-96; BIBL. 15REF.Article

INDOLEAMINE METABOLITES IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS BEFORE AND DURING TREATMENT WITH NORTRIPTYLINE = LES METABOLITES DES INDOLEAMINES DANS LE LIQUIDE CEPHALO-RACHIDIEN DES PATIENTS DEPRIMES AVANT ET APRES TRAITEMENT PAR LA NORTRIPTYLINEASBERG M; BERTILSSON L; TUCK D et al.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 2; PP. 277-286; BIBL. 35REF.Serial Issue

MONOAMINE METABOLITES IN CEREBROSPINAL FLUID DURING TREATMENT OF HYPERTENSION WITH PRAZOSINSEIDEMAN P; BERTILSSON L; HAGLUND K et al.1980; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1980; VOL. 18; NO 5; PP. 399-401; BIBL. 12 REF.Article